Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis

Fig. 3

Overall survival (OS) and progression-free survival (PFS) of patients. a The Waldenström macroglobulinemia with extramedullary involvement (EMWM) group had shorter OS than did the WM patients with only bone marrow involvement (BMWM) group. b In the symptomatic WM patients with standard treatment, the PFS of the EMWM group was also significantly shorter than that of the BMWM group

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us